Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Latest News
All News
EMJ GOLD
Trump administration cuts more than 90% of USAID funding
EMJ GOLD
Eli Lilly plans record $50bn US manufacturing investment
EMJ GOLD
EMA grants accelerated review to Gilead’s PrEP drug
EMJ GOLD
AstraZeneca pays $160m for FibroGen's China subsidary
Latest Articles
All Articles
EMJ GOLD
Chiesi’s Enrico Piccinini on driving action for Rare Disease Day
Find out what the Senior Vice President, EU & International, Rare Diseases, Chiesi Group, thinks the pharma industry should consider on Rare Disease Day.
EMJ GOLD
5 minutes with... Jaime Manzanera, Eisai
Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.
EMJ GOLD
Engaging the medical mind: Does interactivity improve recall?
Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical education.
EMJ GOLD
5 minutes with... Dr Matthew Hickling, Allergan Aesthetics
Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.
Latest Podcasts
All Podcasts
EMJ GOLD
The HBA’s Mary Stutts on tackling bias for better women’s health
Mary Stutts, CEO, HBA, unpacks the key findings of a report exposing critical gaps in doctors’ understanding of women’s health.
EMJ GOLD
Does interactivity boost memory, recall and retention?
Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.
EMJ GOLD
J&J’s Martin Price on World Cancer Day 2025 – Part 2
Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space
EMJ GOLD
J&J’s Martin Price on World Cancer Day 2025 – Part 1
A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.
Latest Infographics
All Infographics
EMJ GOLD
Fostering trust between pharma and HCPs
EMJ GOLD
How HCPs consumed medical content in 2024
EMJ GOLD
The rise, fall and smart allocation of pharma marketing budgets
EMJ GOLD
Finding the interactive edge in medical education